Scholarly Works - Conferences
Conference
Adv Sci (Weinh)
·
April 2024
Patient-Derived Organoids (PDO) and Xenografts (PDX) are the current gold standards for patient-derived models of cancer (PDMC). Nevertheless, how patient tumor cells evolve in these models and the impact on drug response remains unclear. Herein, the trans ...
Full text
Link to item
Cite
Conference
Hepatology
·
June 1, 2023
BACKGROUND AND AIMS: Liver fibrosis results from the accumulation of myofibroblasts (MFs) derived from quiescent HSCs, and yes-associated protein (YAP) controls this state transition. Although fibrosis is also influenced by HSC death and senescence, whethe ...
Full text
Open Access
Link to item
Cite
Conference
Cancer Research
·
October 1, 2014
AbstractGlioblastoma (GBM) is the most common and aggressive primary brain tumor in adults, which is highly resistant to conventional therapies. In GBM, glioblastoma stem cells (GSCs) are critical for the tu ...
Full text
Cite
Conference
BMC Bioinformatics
·
September 11, 2012
Background: The formation of new lymphatic vessels provides an additional route for tumour cells to metastasize. Therefore, inhibiting lymphangiogenesis represents an interesting target in cancer therapy. First evidence suggests that histone deacetylase in ...
Full text
Cite
Conference
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
·
March 6, 2007
Link to item
Cite